Intarcia Therapeutics Garners $75,000,000 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6b1aebf2-476c-46d6-83f3-df1e3595401b
Date
5/6/2016
Company Name
Intarcia Therapeutics
Mailing Address
155 Seaport Boulevard 11th Floor Boston, MA 02210 USA
Company Description
Intarcia Therapeutics, Inc., is a rapidly emerging biopharmaceutical company committed to developing innovative therapies that merge medicine with technology, and have the potential to transform therapeutic categories.
Website
http://www.intarcia.com
Transaction Type
Debt
Transaction Amount
$75,000,000
Transaction Round
Undisclosed
Proceeds Purposes
The company will use the proceeds to ramp up manufacturing to build inventory for a prospective late 2017 commercial launch.
M&A Terms
Venture Investor
Silicon Valley Bank
Venture Investor
MidCap Financial